Kempen & Co Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Kempen & Co. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Kempen & Co. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsYMABY-mAbs Therapeutics$7.08+3.4%10/31/2022Downgraded byKempen & Co-Buy -> NeutralLowView details for Kempen & Co rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 10/31/2022LEGIFLEG Immobilien$78.956/10/2022Upgraded byKempen & Co-Neutral -> BuyLowView details for Kempen & Co rating of LEG Immobilien (OTCMKTS:LEGIF) on 6/10/2022MOLNMolecular Partners$4.29-4.2%4/27/2022Downgraded byKempen & Co-Buy -> NeutralHighView details for Kempen & Co rating of Molecular Partners (NASDAQ:MOLN) on 4/27/2022CNTGCentogene$1.26+0.8%10/7/2020Initiated byKempen & Co-Buy$22.00MediumView details for Kempen & Co rating of Centogene (NASDAQ:CNTG) on 10/7/2020DLNDerwent LondonGBX 2,214-0.7%3/10/2016Reiterated byKempen & Co-NeutralGBX 3,200N/AView details for Kempen & Co rating of Derwent London (LON:DLN) on 3/10/2016UTGUnite GroupGBX 979.50-0.3%2/26/2016Reiterated byKempen & Co-BuyGBX 700N/AView details for Kempen & Co rating of Unite Group (LON:UTG) on 2/26/2016 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. SGROSEGROGBX 831.80-1.2%2/22/2016Reiterated byKempen & Co-SellGBX 405N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 2/22/2016HMSOHammersonGBX 26.96-2.2%2/22/2016Reiterated byKempen & Co-NeutralGBX 600N/AView details for Kempen & Co rating of Hammerson (LON:HMSO) on 2/22/2016SGROSEGROGBX 831.80-1.2%2/3/2016Downgraded byKempen & Co-SellGBX 405N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 2/3/2016HMSOHammersonGBX 26.96-2.2%2/3/2016Reiterated byKempen & Co-NeutralGBX 600N/AView details for Kempen & Co rating of Hammerson (LON:HMSO) on 2/3/2016DLNDerwent LondonGBX 2,214-0.7%2/3/2016Reiterated byKempen & Co-NeutralGBX 3,550N/AView details for Kempen & Co rating of Derwent London (LON:DLN) on 2/3/2016BLNDBritish LandGBX 376.20+0.3%2/3/2016Reiterated byKempen & Co-BuyGBX 805N/AView details for Kempen & Co rating of British Land (LON:BLND) on 2/3/2016LANDLand Securities GroupGBX 643.80-0.5%2/3/2016Reiterated byKempen & Co-BuyGBX 1,240N/AView details for Kempen & Co rating of Land Securities Group (LON:LAND) on 2/3/2016GRIGraingerGBX 261.60-1.3%1/28/2016Reiterated byKempen & Co-NeutralGBX 250N/AView details for Kempen & Co rating of Grainger (LON:GRI) on 1/28/2016GRIGraingerGBX 261.60-1.3%1/4/2016Reiterated byKempen & Co-NeutralGBX 250N/AView details for Kempen & Co rating of Grainger (LON:GRI) on 1/4/2016BYGBig Yellow GroupGBX 1,13712/8/2015Downgraded byKempen & Co-SellGBX 745N/AView details for Kempen & Co rating of Big Yellow Group (LON:BYG) on 12/8/2015DLNDerwent LondonGBX 2,214-0.7%12/8/2015Downgraded byKempen & Co-NeutralGBX 3,950N/AView details for Kempen & Co rating of Derwent London (LON:DLN) on 12/8/2015SGROSEGROGBX 831.80-1.2%11/23/2015Reiterated byKempen & Co-NeutralGBX 430N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 11/23/2015SGROSEGROGBX 831.80-1.2%10/22/2015Reiterated byKempen & Co-NeutralGBX 430N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 10/22/2015UTGUnite GroupGBX 979.50-0.3%10/5/2015Reiterated byKempen & Co-BuyGBX 760N/AView details for Kempen & Co rating of Unite Group (LON:UTG) on 10/5/2015SGROSEGROGBX 831.80-1.2%9/15/2015Upgraded byKempen & Co-NeutralGBX 430N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 9/15/2015UTGUnite GroupGBX 979.50-0.3%8/17/2015Reiterated byKempen & Co-BuyGBX 760N/AView details for Kempen & Co rating of Unite Group (LON:UTG) on 8/17/2015BYGBig Yellow GroupGBX 1,1378/17/2015Reiterated byKempen & Co-BuyGBX 760N/AView details for Kempen & Co rating of Big Yellow Group (LON:BYG) on 8/17/2015GRIGraingerGBX 261.60-1.3%8/17/2015Upgraded byKempen & Co-NeutralGBX 250N/AView details for Kempen & Co rating of Grainger (LON:GRI) on 8/17/2015BLNDBritish LandGBX 376.20+0.3%7/20/2015Reiterated byKempen & Co-OverweightGBX 960N/AView details for Kempen & Co rating of British Land (LON:BLND) on 7/20/2015SGROSEGROGBX 831.80-1.2%3/3/2015Reiterated byKempen & Co-UnderweightGBX 415N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 3/3/2015SGROSEGROGBX 831.80-1.2%2/10/2015Reiterated byKempen & Co-UnderweightGBX 400N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 2/10/2015RWIRenewiGBX 592+0.7%10/6/2014Reiterated byKempen & Co-BuyGBX 1,050N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 10/6/2014RWIRenewiGBX 592+0.7%9/8/2014Reiterated byKempen & Co-BuyGBX 1,210N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 9/8/2014SGROSEGROGBX 831.80-1.2%7/4/2014Reiterated byKempen & Co-NeutralGBX 365N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 7/4/2014RWIRenewiGBX 592+0.7%4/1/2014Reiterated byKempen & Co-BuyGBX 1,320N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 4/1/2014RWIRenewiGBX 592+0.7%2/3/2014Reiterated byKempen & Co-buyGBX 1,320N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 2/3/2014SGROSEGROGBX 831.80-1.2%1/8/2014Reiterated byKempen & Co-UnderweightGBX 315N/AView details for Kempen & Co rating of SEGRO (LON:SGRO) on 1/8/2014GRIGraingerGBX 261.60-1.3%1/8/2014Reiterated byKempen & Co-UnderweightGBX 195N/AView details for Kempen & Co rating of Grainger (LON:GRI) on 1/8/2014SMPSt. Modwen PropertiesGBX 5591/8/2014Reiterated byKempen & Co-OverweightGBX 405N/AView details for Kempen & Co rating of St. Modwen Properties (LON:SMP) on 1/8/2014UTGUnite GroupGBX 979.50-0.3%1/8/2014Reiterated byKempen & Co-OverweightGBX 435N/AView details for Kempen & Co rating of Unite Group (LON:UTG) on 1/8/2014RWIRenewiGBX 592+0.7%1/6/2014Reiterated byKempen & Co-BuyGBX 1,320N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 1/6/2014KKPNYKoninklijke KPN$3.376/13/2013Reiterated byKempen & Co-Buy$2.00N/AView details for Kempen & Co rating of Koninklijke KPN (OTCMKTS:KKPNY) on 6/13/2013MTArcelorMittal$25.35-0.7%6/4/2013Reiterated byKempen & Co-Buy$42.00N/AView details for Kempen & Co rating of ArcelorMittal (NYSE:MT) on 6/4/2013KKPNYKoninklijke KPN$3.376/3/2013Upgraded byKempen & Co-Buy$2.00N/AView details for Kempen & Co rating of Koninklijke KPN (OTCMKTS:KKPNY) on 6/3/2013RWIRenewiGBX 592+0.7%5/24/2013Reiterated byKempen & Co-HoldGBX 820N/AView details for Kempen & Co rating of Renewi (LON:RWI) on 5/24/2013KGPKingspan GroupGBX 72.80-3.4%5/23/2013Upgraded byKempen & Co-BuyGBX 11N/AView details for Kempen & Co rating of Kingspan Group (LON:KGP) on 5/23/2013 MarketBeat Community Rating for Kempen & CoCommunity Ranking: 2.7 out of 5 (2.7 of 5 stars)Outperform Votes: 22,170 (Vote Outperform)Underperform Votes: 18,862 (Vote Underperform)Total Votes: 41,032MarketBeat's community ratings are surveys of what our community members think about Kempen & Co and other research firms. Vote "Outperform" if you believe Kempen & Co's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Kempen & Co's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.